Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,783 | $400,602 | $417,236 | $437,716 |
| - Cash | $306 | $56,288 | $52,405 | $50,873 |
| + Debt | $5 | $749 | $789 | $846 |
| Enterprise Value | $2,481 | $345,063 | $365,620 | $387,689 |
| Revenue | $291 | $36,411 | $32,607 | $51,141 |
| % Growth | -99.2% | 11.7% | -36.2% | – |
| Gross Profit | $151 | $19,462 | $16,683 | $24,907 |
| % Margin | 52% | 53.5% | 51.2% | 48.7% |
| EBITDA | $49 | $6,325 | $4,486 | $8,646 |
| % Margin | 16.7% | 17.4% | 13.8% | 16.9% |
| Net Income | $25 | $1,543 | $1,624 | $4,723 |
| % Margin | 8.5% | 4.2% | 5% | 9.2% |
| EPS Diluted | 0.33 | 20.76 | 21.85 | 63.53 |
| % Growth | -98.4% | -5% | -65.6% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |